Jibiki K, Saxena B B
Acta Endocrinol (Copenh). 1978 Apr;87(4):838-44. doi: 10.1530/acta.0.0870838.
In the receptor-immunoassay, the binding of anti-HCG-beta sera to 125I-HCG and 125I-HLH is measured in the presence of bovine corpus luteum "receptor". Anti-sera specific for HCG show little binding with 125I-HLH. The receptor-immunoassay permits an evaluation of specificity, affinity and the ability of anti-HCG-beta sera to compete with the "receptor" for binding to 125I-HCG.
在受体免疫测定中,在存在牛黄体“受体”的情况下,测定抗人绒毛膜促性腺激素β血清与125I-人绒毛膜促性腺激素及125I-人促黄体激素的结合情况。对人绒毛膜促性腺激素具有特异性的抗血清与125I-人促黄体激素的结合很少。受体免疫测定可用于评估抗人绒毛膜促性腺激素β血清的特异性、亲和力以及与“受体”竞争结合125I-人绒毛膜促性腺激素的能力。